Raptor Pharm (RPTP) Misses Q4 EPS by 3c

Raptor Pharm (NASDAQ: RPTP) reported Q4 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $0 versus the consensus estimate of $250 thousand.

For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c